Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference34 articles.
1. WHO/ISUP classification, grading and pathological staging of renal cell carcinoma: standards and controversies.;Warren;World J Urol.,2018
2. A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinoma.;Huang;Clin Cancer Res.,2010
3. MET inhibition in clear cell renal cell carcinoma.;Xie;J Cancer.,2016
4. Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma.;Chen;Oncol Rep.,2020
5. Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.;Zhou;Oncogene.,2016
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic and diagnostic applications of exosomes in colorectal cancer;Medical Oncology;2024-07-20
2. An oncogenic role of lncRNA SNHG1 promotes ATG7 expression and autophagy involving tumor progression and sunitinib resistance of Renal Cell Carcinoma;Cell Death Discovery;2024-06-08
3. Molecular and functional characterization of reversible‐sunitinib‐tolerance state in human renal cell carcinoma;Journal of Cellular and Molecular Medicine;2024-05
4. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics;British Journal of Pharmacology;2023-10-19
5. Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma;Frontiers in Oncology;2023-08-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3